UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 839

Sortiert nach

Migraine Progression: A Systematic Review

Headache, 2019-03, Vol.59 (3), p.306-338

2019

Link zum Volltext

Verfügbarkeit prüfen

Trajectories of frailty in aging: Prospective cohort study

PloS one, 2021-07, Vol.16 (7), p.e0253976-e0253976

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of neck pain in migraine and tension-type headache: A population study

Cephalalgia, 2015-03, Vol.35 (3), p.211-219

2015

Link zum Volltext

Verfügbarkeit prüfen

Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson's Disease

PloS one, 2016-10, Vol.11 (10), p.e0162799

2016

Link zum Volltext

Verfügbarkeit prüfen

Psychiatric comorbidities of episodic and chronic migraine

Journal of neurology, 2013-08, Vol.260 (8), p.1960-1969

2013

Link zum Volltext

Verfügbarkeit prüfen

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

Cephalalgia, 2016-08, Vol.36 (9), p.887-898

2016

Link zum Volltext

Verfügbarkeit prüfen

Post-Dural Puncture Headache: Part I Diagnosis, Epidemiology, Etiology, and Pathophysiology

Headache, 2010-07, Vol.50 (7), p.1144-1152

2010

Link zum Volltext

Verfügbarkeit prüfen

Reliability and Validity of Ambulatory Cognitive Assessments

Assessment (Odessa, Fla.), 2018-01, Vol.25 (1), p.14-30

2018

Link zum Volltext

Verfügbarkeit prüfen

Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study

Headache, 2013-09, Vol.53 (8), p.1278-1299

2013

Link zum Volltext

Verfügbarkeit prüfen

Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study

Headache, 2012-11, Vol.52 (10), p.1456-1470

2012

Link zum Volltext

Verfügbarkeit prüfen

The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results

Cephalalgia, 2015-06, Vol.35 (7), p.563-578

2015

Link zum Volltext

Verfügbarkeit prüfen

Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population-Based Study

Headache, 2008-09, Vol.48 (8), p.1157-1168

2008

Link zum Volltext

Verfügbarkeit prüfen

Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study

Journal of headache and pain, 2020-03, Vol.21 (1), p.23-23, Article 23

2020

Link zum Volltext

Verfügbarkeit prüfen

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial

Headache, 2020-01, Vol.60 (1), p.141-152

2020

Link zum Volltext

Verfügbarkeit prüfen

Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design

Journal of headache and pain, 2017-10, Vol.18 (1), p.101-101, Article 101

2017

Link zum Volltext

Verfügbarkeit prüfen

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Headache, 2010-06, Vol.50 (6), p.921-936

2010

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)

Headache, 2013-04, Vol.53 (4), p.644-655

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine

Headache, 2020-09, Vol.60 (8), p.1734-1742

2020

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)

Cephalalgia, 2018-05, Vol.38 (6), p.1038-1048

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study

Mayo Clinic proceedings, 2016-05, Vol.91 (5), p.596-611

2016

Link zum Volltext

Verfügbarkeit prüfen

Perceived Stress Is Differentially Related to Hippocampal Subfield Volumes among Older Adults

PloS one, 2016-05, Vol.11 (5), p.e0154530-e0154530

2016

Link zum Volltext

Verfügbarkeit prüfen

Gait Dysfunction in Mild Cognitive Impairment Syndromes

Journal of the American Geriatrics Society (JAGS), 2008-07, Vol.56 (7), p.1244-1251

2008

Link zum Volltext

Verfügbarkeit prüfen

Comorbidities of epilepsy: Results from the Epilepsy Comorbidities and Health (EPIC) survey

Epilepsia (Copenhagen), 2011-02, Vol.52 (2), p.308-315

2011

Link zum Volltext

Verfügbarkeit prüfen

Modifiable Risk Factors for Migraine Progression

Headache, 2006-10, Vol.46 (9), p.1334-1343

2006

Link zum Volltext

Verfügbarkeit prüfen

T‐MoCA: A valid phone screen for cognitive impairment in diverse community samples

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2021, Vol.13 (1), p.e12144-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 839

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(771)
Mit Volltextzugriff
(751)

Publikationsform

Sprache

Englisch
(838)
Japanisch
(87)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Migraine Progression: A Systematic Review

Trajectories of frailty in aging: Prospective cohort study

Prevalence of neck pain in migraine and tension-type headache: A population study

Digitized Spiral Drawing: A Possible Biomarker for Early Parkinson's Disease

Psychiatric comorbidities of episodic and chronic migraine

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine

Post-Dural Puncture Headache: Part I Diagnosis, Epidemiology, Etiology, and Pathophysiology

Reliability and Validity of Ambulatory Cognitive Assessments

Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study

Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study

The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results

Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population-Based Study

Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial

Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine

A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study)

Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study

Perceived Stress Is Differentially Related to Hippocampal Subfield Volumes among Older Adults

Gait Dysfunction in Mild Cognitive Impairment Syndromes

Comorbidities of epilepsy: Results from the Epilepsy Comorbidities and Health (EPIC) survey

Modifiable Risk Factors for Migraine Progression

T‐MoCA: A valid phone screen for cognitive impairment in diverse community samples

Aktive Filter

Suchergebnisse filtern